Testosterone Lawsuit News: July Conference on Bellweather Trials
St. Louis, MO (PRWEB) June 30, 2015 -- In the latest testosterone lawsuit news, attorneys handling national testosterone claims alleging heart attack and stroke incidents are linked to testosterone replacement therapy announce an upcoming Case Management Conference to take place after Independence Day. The Case Management Conference is scheduled for July 9, 2015, according to court documents.* The testosterone lawsuit multidistrict litigation now includes at least 1,768 separate claims filed around the country, according to the Judicial Panel on Multidistrict Litigation’s case list, which was updated on June 15, 2015.**
“Determining how exactly the bellweather trials will occur in this litigation has been a source of ongoing discussion,” explained a representative of the Onder Law Firm. “In the court documents, all the testosterone lawsuits make similar allegations – that men who took testosterone allegedly suffered heart attacks and stroke in connection to the substance. One complexity of the testosterone lawsuits is that there are a number of defendants – more than ten pharmaceutical companies are named in the official court documents. The court has determined that bellweather trials will include only the original claims – allegations related to cardiovascular events stemming from the testosterone drug Androgel – as reflected by court documents. But all the details of the bellweather cases are yet to be fixed, and we anticipate this upcoming Case Management Conference to continue to address them.”
Testosterone replacement therapy is a medical supplement regulated by the FDA which has been approved for use in men diagnosed with hypogonadism, according to court documents. These testosterone lawsuits allege that the drug companies responsible for marketing testosterone replacement therapies engaged in aggressive advertising campaigns that encouraged men to self-diagnose a mythical disease called “Low T”, according to court documents. Testosterone treatment products have been widely diagnosed to men who have not been diagnosed with hypogonadism, a medical condition in which the body does not naturally produce enough testosterone, according to court documents. The testosterone lawsuits consolidated in this multidistrict litigation allege that pharmaceutical companies glossed over the risks associated with the drugs, encouraging the casual use of an allegedly harmful substance, according to court documents.
The risks of arterial and venous blood clots from testosterone replacement products, and their corresponding health problems of heart attack, stroke, and other cardiovascular problems, have been the subject of two FDA warnings: Heart attack and stroke are side effects linked to arterial blood clots, the subject of an FDA warning from January 31, 2014.*** Deep vein thrombosis and pulmonary embolism are health conditions that can be caused by venous blood clots. This health condition and its connection to AndroGel and other testosterone drugs is outlined in another FDA warning, from June 19, 2014. **** MDL No. 2545 includes testosterone lawsuit claims for arterial blood clot problems only, such as heart attack and stroke, according to court documents.
These testosterone attorneys offers comprehensive testosterone lawsuit news and information at their website. The firm is known for its success representing individuals against major corporation through pharmaceutical, product liability, and personal injury lawsuits. Individuals who believe they may have grounds to file a testosterone lawsuit alleging heart attack or stroke may contact the firm for a free case review through the website.
Lawyers handling testosterone lawsuit claims at The Onder Law Firm believe qualifying persons may be entitled to real compensation and offer no-cost, no-obligation case review to persons or family members of those who have suffered heart attack, stroke, or another serious health problem possibly related to AndroGel, Testim, or another testosterone product.
The Onder Law Firm welcomes testosterone lawsuit inquiries from law firms in regards to handling them or working as co-counsel.
About The Onder Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The pharmaceutical and medical device litigators at The Onder Law Firm have represented thousands of Americans in lawsuits against multinational conglomerates from products liability for manufacture of defective or dangerous products to deceptive advertising practices. Other firms throughout the nation often seek its experience and expertise on complex litigation. It is also a recognized leader in products liability cases such as window blind cord strangulation. The Onder Law Firm offers information from attorneys handling testosterone lawsuits at http://www.TestimTestosteroneLawsuitCenter.com.
*Testosterone Replacement Therapy Products Liability Litigation, MDL 2545, U.S. District Court, Northern District of Illinois
**jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-June-15-2015.pdf
***fda.gov/drugs/drugsafety/ucm401746.htm
****fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm384225.htm
Michael Gudeman, Gudeman Group, +1 314-614-8709, [email protected]
Share this article